|
Mar 14
|
Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?
|
|
Mar 14
|
Is Alkermes plc (ALKS) the Best Healthcare Stock For Long-Term Investment?
|
|
Mar 14
|
Alkermes' (NASDAQ:ALKS) investors will be pleased with their splendid 140% return over the last five years
|
|
Mar 13
|
Alkermes Facing Near-Term Headwinds Across Existing Franchises, Royalties, RBC Says
|
|
Mar 1
|
Alkermes plc (ALKS): Among the Best Psychedelic Stocks to Buy in 2025
|
|
Feb 26
|
Alkermes to Participate in Upcoming Investor Conferences
|
|
Jan 13
|
Onera’s validation trial of home polysomnography sleep device succeeds
|
|
Jan 2
|
Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Dec 31
|
Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes plc (NASDAQ:ALKS)?
|
|
Oct 12
|
Is Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?
|
|
Oct 9
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Oct 2
|
Alkermes (NASDAQ:ALKS) shareholder returns have been favorable, earning 62% in 5 years
|
|
Sep 25
|
Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
|
|
Sep 23
|
Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
|
|
Sep 13
|
Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
|
|
Aug 30
|
Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report?
|
|
Aug 29
|
Incyte (INCY) Up 0.9% Since Last Earnings Report: Can It Continue?
|
|
Aug 28
|
Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Jul 31
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jul 30
|
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
|